Exousia Bio, Inc.
LMMYOTCOther · Services-Educational Services · WY · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $3,750 | $11,500 | $0 | $0 |
| Operating income | — | — | −$56,421 | −$937 |
| Net income | $51,395 | −$25,807 | −$56,421 | −$937 |
| Total assets | $0 | $27,453 | $37,044 | $53,996 |
| Total liabilities | $0 | $82,348 | $66,132 | $54,433 |
| Equity | $0 | −$54,895 | −$29,088 | −$437 |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares out. | 7.8M | 7.8M | 7.8M | 5.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 1370.5%
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.00
- Revenue growth (YoY)
- −67.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Negative operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Apr 14, 2026
- NT 10-Qmissed a reporting deadline ↗Jan 15, 2026
- NT 10-Qmissed a reporting deadline ↗Oct 16, 2025
- NT 10-Kmissed a reporting deadline ↗Aug 29, 2025
- NT 10-Qmissed a reporting deadline ↗Apr 14, 2025
- NT 10-Kmissed a reporting deadline ↗Aug 30, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 10 | 1.0 | 0.0% |
| Apr 30, 2026 | 10 | 1.0 | +100.0% |
| Dec 31, 2025 | 0 | 0.0 | -100.0% |
| Dec 15, 2025 | 50 | 1.0 | +100.0% |
| Jun 13, 2025 | 1,440 | 1.0 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Change in control · Director / officer changeNov 17, 2025
- Change in control · Director / officer changeDec 17, 2024
- Changed auditorAug 29, 2024
- Director / officer changeMar 17, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- NT 10-QEXTENSIONApr 14, 2026
- 10-QFORM 10-Q FOR NOV 2025Mar 17, 2026
- NT 10-QEXTENSIONJan 15, 2026
- 8-KFORM 8-KNov 17, 2025
- 10-QNov 17, 2025
- 10-KANNUAL REPORTOct 17, 2025
- NT 10-QEXTENSIONOct 16, 2025
- NT 10-KEXTENSIONAug 29, 2025
- 10-QFORM 10-QApr 24, 2025
- NT 10-QEXTENSIONApr 14, 2025
- 10-QFORM 10-Q FOR NOV 2024Jan 10, 2025
- 8-KFORM 8-KDec 17, 2024
- 10-QQUARTERLY REPORTOct 11, 2024
- 10-KANNUAL REPORTAug 30, 2024
- NT 10-KFORM 12B-25Aug 30, 2024